Von Willebrand Disease (Type 3) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Von Willebrand Disease (Type 3)
Von Willebrand Disease (vWD) Type 3 is the most severe and rare form of this inherited bleeding disorder, characterized by very low or absent von Willebrand factor. Managing it requires lifelong treatment, which can be costly. TheDrugClub is dedicated to helping individuals and families afford the vital medications needed to live well with vWD Type 3, easing the financial burden.
What is Von Willebrand Disease Type 3?
Von Willebrand Disease (vWD) is the most common inherited bleeding disorder, affecting the blood's ability to clot. It's caused by a deficiency or defect in von Willebrand factor (vWF), a protein essential for proper blood clotting. Among its types, Type 3 is the most severe and rarest form. Individuals with vWD Type 3 have very low or virtually absent levels of vWF, and often significantly reduced levels of Factor VIII (FVIII), another crucial clotting protein.
This severe deficiency leads to frequent and serious bleeding episodes. Symptoms can include spontaneous bleeding from mucous membranes (like frequent nosebleeds and gum bleeding), easy and severe bruising, heavy and prolonged menstrual bleeding (menorrhagia), and significant bleeding after injuries, surgery, or dental procedures. More concerning are spontaneous bleeds into joints and muscles, which can cause pain, damage, and long-term disability if not promptly treated. Because it's an inherited condition, typically passed down in an autosomal recessive pattern, both parents must carry the gene for a child to be affected.
Common Treatments and Medications
Managing vWD Type 3 primarily involves replacing the missing clotting factors. The mainstay of treatment is replacement therapy with concentrated clotting factor products that contain both von Willebrand factor and Factor VIII. Medications like Humate-P, Wilate, and Alphanate are
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.